Article info

Download PDFPDF
Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis
  1. Correspondence to Professor Jonathan Rhodes, Department of Gastroenterology, University of Liverpool, Duncan Building, Daulby St, Liverpool L69 3GA, UK; rhodesjm{at}liverpool.ac.uk
View Full Text

Citation

Leiper K, Martin K, Ellis A, et al
Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis

Publication history

  • Revised March 1, 2011
  • Accepted March 7, 2011
  • First published April 6, 2011.
Online issue publication 
October 26, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.